Skip to main content

Advertisement

Log in

How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease

  • Multicenter Seminars: IBD (MUSE: IBD)
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148:639–651.e28. https://doi.org/10.1053/j.gastro.2015.01.031.

    Article  PubMed  Google Scholar 

  2. Participants in the Paris Workshop. The Paris classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc. 2003;58:S3–S43.

    Article  Google Scholar 

  3. Choi CR, Ignjatovic-Wilson A, Askari A, et al. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer. Am J Gastroenterol. 2015;110:1461–1471. https://doi.org/10.1038/ajg.2015.248.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Thomas T, Abrams KA, Robinson RJ, et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25:657–668.

    Article  CAS  PubMed  Google Scholar 

  5. Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004;2:534–541. https://doi.org/10.1016/S1542-3565(04)00237-X.

    Article  PubMed  Google Scholar 

  6. Sanduleanu S, Kaltenbach T, Barkun A, et al. Roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice. Gastrointest Endosc. 2016;83:212–222.

    Article  Google Scholar 

  7. Naymagon S, Ullman TA. Chromoendoscopy and dysplasia surveillance in inflammatory bowel disease: past, present, and future. Gastroenterol Hepatol. 2015;11:304–311.

    Google Scholar 

  8. Lopez A, Collet-Fenetrier B, Belle A, Peyrin-Biroulet L. Patients’ knowledge and fear of colorectal cancer risk in inflammatory bowel disease: colorectal cancer risk in IBD. J Dig Dis. 2016;17:383–391. https://doi.org/10.1111/1751-2980.12356.

    Article  PubMed  Google Scholar 

  9. Baars JE, Siegel CA, van’t Spijker A, Markus T, Kuipers EJ, van der Woude CJ. Inflammatory bowel disease-patients are insufficiently educated about the basic characteristics of their disease and the associated risk of colorectal cancer. Dig Liver Dis. 2010;42:777–784.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kendall R. Beck.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lewin, S.M., Wen, K.W., Velayos, F.S. et al. How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease. Dig Dis Sci 64, 52–55 (2019). https://doi.org/10.1007/s10620-018-5409-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-018-5409-5

Keywords

Navigation